FDA FAERS Dataset
收藏资源简介:
## Overview Unlock pharmacovigilance intelligence from **18M+ adverse event reports** spanning two decades of FDA safety data. The FDA Adverse Event Reporting System (FAERS) captures every reported drug safety signal in the United States, providing the foundation for drug safety surveillance and competitive intelligence. **Dataset Size:** 70+ GB | **191M+ records** | **Updated quarterly with daily corrections** > **[Start Free Trial](https://trial.dataplex-consulting.com)** | **[Purchase Full Access](https://checkout.dataplex-consulting.com/b/eVqaEQcXFdGoeUocKgbQY03)** ### What's Included - **drug__events** - Core adverse event reports with demographics and outcomes (18M+ reports) - **drug__events_drugs** - Drug details per event: suspect, concomitant, interacting (70M+ records) - **drug__events_reactions** - MedDRA-coded reactions per event (55M+ reactions) - **drug__events_patients** - Anonymized patient demographics: age, sex, weight (18M+ patients) - **drug__agg_safety_trends** - Pre-aggregated monthly/quarterly safety trends (27M+ rows) - **drug__agg_drug_reaction_associations** - Drug-reaction pair statistics with PRR metrics (130K+ associations) --- ## Use Cases ### Pharmaceutical & Biotech - **Post-market surveillance**: Monitor safety signals across your drug portfolio - **Competitive intelligence**: Benchmark adverse event rates against competitors - **Regulatory submissions**: Support safety sections with real-world evidence - **Label updates**: Identify emerging safety concerns before they escalate ### Healthcare & Research - **Safety signal detection**: Identify unusual adverse event patterns early - **Demographic risk stratification**: Analyze safety profiles by age, sex, and weight - **Drug interaction analysis**: Examine concomitant medication patterns - **Outcome severity analysis**: Track death, hospitalization, and disability rates ### Consulting & Analytics - **Market intelligence**: Size the safety burden for any therapeutic area - **Due diligence**: Assess drug safety profiles for M&A and investment decisions - **Trend analysis**: Track reporting patterns over time with pre-built aggregates --- ## Data Quality & Updates - **Source**: FDA Adverse Event Reporting System (FAERS) public data - **History**: Complete data back to 2004 - **Updates**: Quarterly bulk releases + daily corrections and amendments - **Coding**: MedDRA standardized reaction terms - **Normalization**: Drug names normalized, duplicates flagged --- ## Getting Started ### Start a Free Trial Get 14 days of access to explore the FDA FAERS dataset: **[Start Free Trial](https://trial.dataplex-consulting.com)** Trial includes: - Full schema access with sample data - Pre-built analytics tables - Databricks notebook with example queries ### Get Full Access Ready for production use? Get unlimited access to all 18M+ adverse event reports: **[Purchase Full Access](https://checkout.dataplex-consulting.com/b/eVqaEQcXFdGoeUocKgbQY03)** Full access includes: - Complete historical data (2004-present) - All 191M+ records across all tables - Pre-aggregated analytics tables - Quarterly updates within days of FDA release - Daily corrections and amendments --- ## Documentation & Support - **Full Documentation**: [docs.dataplex-consulting.com/fda-faers-dataset](https://docs.dataplex-consulting.com/healthcare-data-catalog/fda-faers-dataset) - **Data Dictionary**: Comprehensive field-level documentation - **Sample Notebooks**: Ready-to-run Databricks notebooks - **Support**: support@dataplex-consulting.com --- ## Related Products - **FDA MAUDE** - 14M+ medical device adverse events - **CMS Medicare/Medicaid** - 73B+ claims and provider records - **NPI Registry** - 8M+ healthcare provider directory - **CDC Public Health** - 1.7B+ population health records --- *Data provided by Dataplex Consulting | [dataplex-consulting.com](https://dataplex-consulting.com)*




